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Abstract The present study validated the accuracy of data
from a self-reported questionnaire on smoking behaviour
with the use of exhaled carbon monoxide (CO) level
measurements in two groups of patients. Group 1 included
patients referred to an oral medicine unit, whereas group 2
was recruited from the daily outpatient service. All patients
filled in a standardized questionnaire regarding their current
and former smoking habits. Additionally, exhaled CO levels
were measured using a monitor. A total of 121 patients
were included in group 1, and 116 patients were included
in group 2. The mean value of exhaled CO was 7.6 ppm
in the first group and 9.2 ppm in the second group. The
mean CO values did not statistically significantly differ
between the two groups. The two exhaled CO level
measurements taken for each patient exhibited very good
correlation (Spearman's coefficient of 0.9857). Smokers
had a mean difference of exhaled CO values of 13.95 ppm
(p<0.001) compared to non-smokers adjusted for the first or
second group. The consumption of one additional pack year
resulted in an increase in CO values of 0.16 ppm (p=0.003).
The consumption of one additional cigarette per day
elevated the CO measurements by 0.88 ppm (p<0.001).
Based on these results, the correlations between the self-
reported smoking habits and exhaled CO values are robust
and highly reproducible. CO monitors may offer a non-
invasive method to objectively assess current smoking
behaviour and to monitor tobacco use cessation attempts in
the dental setting.
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Introduction
Smoking harms nearly every organ of the body, leading to a
range of diseases and premature mortality. Doll and
colleagues reported that prolonged cigarette smoking from
early adulthood tripled age-specific mortality rates, but
cessation at age 50 halved the hazard, and cessation at age
30 avoided almost all of it [1]. There are some 4,000 known
chemicals in tobacco smoke, and more than 50 of them are
known to cause cancer in humans. The lung is the site
considered at highest relative risk of cancer due to smoking
[2]. Following lung cancer the highest relative risks are
observed for the larynx and oral cavity [3]. A recent meta-
analysis analysed the data from 12 studies estimating the
oral cancer risk in the USA, Uruguay, Italy, Sweden, India,
China, Taiwan and Korea [4]. The reported pooled cancer
risk estimate was 3.43 times higher in smokers compared to
non-smokers. Besides oral squamous cell carcinoma, other
oral diseases that are considered to be related to cigarette
smoking include oral leukoplakia, periodontal disease,
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tooth loss, gingival recession and other benign mucosal
disorders such as smoker's melanosis and smoker's palate
[5–7].
It has been demonstrated that patients expect their oral
health professionals to ask about their smoking status as
part of the overall health assessment [8, 9]. To estimate the
prevalence and also the quantity of smoking, self-reported
information is widely used in medicine. Nevertheless,
studies have shown that self-reported data on tobacco use
may underestimate the true prevalence [10–12]. To gain
objective data on smoking and/or exposure to environmen-
tal tobacco smoke, the use of cotinine levels in blood, saliva
or urine, and carbon monoxide in the exhaled air were
evaluated as potential assessment methods [13]. It has been
documented that interventions for tobacco users in the
dental setting increase the odds of quitting smoking [9].
Nevertheless, the accuracy of self-reported smoking has
never been analysed using biochemical methods for
patients seeking dental healthcare. The aim of this study
was to investigate the accuracy of self-reported data of the
smoking habits through the use of exhaled carbon monox-
ide level measurements in two different groups of patients
in a dental setting: patients referred to the oral medicine
unit versus patients from the daily outpatient service.
Materials and methods
Study sample and clinical examination
This study was designed as a study with two cohorts of
patients to validate the accuracy of data from a self-reported
questionnaire on smoking behaviour with the use of
exhaled carbon monoxide (CO) level measurements in
two different groups of patients. Group 1 included patients
referred to the oral medicine unit of the Department of
Oral Surgery and Stomatology, University of Bern, for
diagnosis and treatment of oral mucosal lesions in the
period between September and December 2010. The
study protocol was approved by the standing ethics
committee for clinical studies in the State of Bern. All
patients were examined following the same protocol by
residents of the department, including thorough medical
history, recent dental/stomatological history, extra- and
intraoral examination and oral biopsy and radiographic
imaging where necessary. All smokers underwent brief
counselling for smoking cessation (behavioural intervention)
as recommended in the consensus report of the First
European Workshop on Tobacco Use Prevention and
Cessation for Oral Health Professionals [14]. In group 2,
patients from the daily outpatient service of the Department
of Oral Surgery and Stomatology, University of Bern, were
included during the same study period.
Assessment of smoking behaviour and questionnaire data
Before commencement of the initial examination, all patients
in both groups had to fill out a standardized questionnaire
regarding their current and former smoking habits [15]. This
questionnaire included the following parameters:
& History of smoking: All patients were asked whether
they were non-smokers, former smokers or current
smokers. The current and former smokers had to
indicate the number of cigarettes smoked per day
(including the time period since they started smoking)
to allow for calculation of a pack year value. The
current smokers were classified into two groups: heavy
smokers (>10 cigarettes smoked per day) and light
smokers (1–10 cigarettes smoked per day).
& Additionally, in all patients, exhaled CO levels were
measured using a monitor device (piCO+ Smokerlyzer;
Bedfont Scientific Ltd., Kent, United Kingdom). To
ensure that measurements were standardized, each patient
was required to exhale completely, take a deep breath and
hold it for 15 s before exhaling fully and slowly into the
mouthpiece of the monitor. Furthermore, each patient was
instructed to seal their lips tightly around the mouthpiece
so that no air escaped from the measuring device when
exhaling [16, 17]. The device measures the exhaled CO
concentration in parts per million (ppm) with a range
from 0–100. The manufacturer states that the device
is accurate to ±2% based on the repeatability of
readings (http://www.bedfont.com/smokerlyzer/pico+).
For all study participants, two CO values were
measured to validate the reproducibility of the method.
The CO measurements were classified into three groups
(based on recommendations by the manufacturer):
0–10 ppm, non-/former smokers; 11–25 ppm, light
smokers and >25 ppm, heavy smokers.
& All patients were examined in the morning between
8.00 a.m. and 12.00 noon.
Statistical analysis
First, all data were analysed using descriptive statistics.
Between group differences of continuous and categorical
variables were compared using the t test, Wilcoxon rank sum
test or chi-square test where appropriate. The influence of the
current smoking status, cumulated pack year values and
number of cigarettes per day on exhaled CO levels were
evaluated using a linear regression model, adjusted for
groups 1 and 2 (oral medicine referrals or patients attending
the outpatient service).
The significance level chosen for all statistical tests was p≤
0.05. All statistical analyses were performed using a software
package (Stata 11.1; StataCorp, College Station, TX, USA).
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Results
Study population
A total of 121 patients were included in group 1 (oral
medicine referrals). This group was comprised of 44 male
and 77 female participants with a mean age of 58.9 years
(minimum 17 years, maximum 84.5 years). In group 2
(outpatient service), a total of 116 patients were included.
This group was comprised of 65 male and 51 female
participants with a mean age of 44.3 years (minimum
17 years, maximum 90 years).
Questionnaire analysis
Group 1 was comprised of 44 current (36.4% of 121
patients included) and 36 former smokers (29.8%) with a
mean pack year value of 21 (range from 0.5 to 105) and a
mean of 4.8 cigarettes per day (range from 0 to 40, Table 1).
No malignant mucosal disease was diagnosed in any of the
included patients. Group 2 was comprised of 44 current
(37.9% of 116 patients included) and 26 former smokers
(22.4%) with a mean pack year value of 10.7 (range from
0.5 to 70) and a mean of 4.5 cigarettes per day (range from
0 to 45).
Between both groups of patients analysed, there was a
statistically significant difference regarding age (p<0.0001)
and gender (p=0.002) with patients being older and more
frequently female in the oral medicine referral group. For
the distribution of current and former smokers, there was
no statistically significant difference between both groups
(p=0.407). Regarding the difference in pack year values,
the difference between the groups was statistically signif-
icant (p=0.0004). Nevertheless, the difference in cigarettes
per day was not statistically significant for the smokers in
both populations (p=0.8068).
Exhaled CO level analysis
For the two exhaled CO level measurements taken for each
patient included in both groups, the data exhibited very
good correlation with a Spearman's coefficient of 0.9857.
Because of these almost identical CO values, only the
initial measurements were used for further analyses.
In group 1, the mean value of exhaled CO was 7.6 ppm
(range of 0–42 ppm). In group 2, the mean value of exhaled
CO was 9.2 ppm (range of 1–76 ppm). There was no
statistically significant difference in mean CO values
between the two groups analysed (p=0.8890). For both
groups, non-smokers had a mean value of 3.06 ppm,
whereas current smokers had a mean value of 16.97 ppm.
Former smokers had a mean value of 3.68 ppm (Table 2).
Correlation between self-reported data and exhaled
CO levels
In both groups, the highest CO values were found for
current smokers, for patients with higher cumulated pack
year values and more cigarettes consumed per day (Table 3).
Smokers had a mean difference in exhaled CO values of
13.95 ppm (95% CI 11.60–16.30 ppm; p<0.001) compared
to non-smokers adjusted for groups 1 and 2. For former
smokers compared to never smokers, the difference was
not statistically significant with a mean difference of
0.78 ppm (95% CI −1.82–3.36 ppm; p=0.55). For all
included subjects, the consumption of one pack year more
resulted in an increase in exhaled CO value of 0.16 ppm
(95% CI 0.06–0.26 ppm; p=0.003). The consumption of
one additional cigarette per day elevated the CO measure-
ments by 0.88 ppm (95% CI 0.77–0.98 ppm; p<0.001).
Discussion
On a global scale, the use of tobacco products is increasing,
although there is a clear trend towards a decrease in high-
income countries. Overall in Europe, the prevalence of
cigarette smoking has stabilised at approximately 28.6% in
the adult population (40% male versus 18.2% female).
However, there is no visible decline for countries in
southern and eastern Europe such as Greece with more
than 50% smokers (male, 63.6%; female, 39.8%) [18, 19].
Table 1 Characteristics of the patients in the two groups regarding self-reported data on smoking habits (smoking status, cumulated pack year
value and amount of cigarettes smoked per day)
Group Mean age (95% CI) Never smokers
(% in group)
Current smokers
(% in group)
Former smokers
(% in group)
Mean py (95% CI) Mean amount of cigarettes
per day (range)
Group 1 58.91* (56.61–61–20) 41 (33.88) 44 (36.36) 36 (29.75) 21.12* (16.11–25.92) 4.83 (0–40)
Group 2 44.32* (41–46–47.19) 46 (39.66) 44 (37.93) 26 (22.41) 10.71* (7.75–13.68) 4.50 (0–45)
Group 1, oral medicine referral group; group 2, outpatient group
py cumulated pack year value, 95% CI 95% confidence interval
*p<0.05, statistically significant difference
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In this study, the patients analysed included more smokers
than the average European population, with 36.4% being
smokers in group 1 (oral medicine) and 37.9% in group 2
(outpatients). In a recent study focusing on patients'
awareness of the potential health benefits of smoking
cessation, only 27% of the patients reported to be current
smokers [20]. In contrast to this study, the patients were
evaluated using self-reported data on smoking habits alone.
Additionally, all patients were recruited from an oral
medicine unit solely. Different results in this recent study
could be due to the long enrolment period of 3.5 years, the
much larger population evaluated and the fact that benefits
of smoking cessation were specifically addressed and thus
patients demonstrated an increased awareness of the
negative impact of smoking.
Among the factors leading to a decline in cigarette
smoking in the United States of America and Europe, the
two most important measures in the past decade were the
increase in the number of smoke-free public places and the
increased taxation of cigarettes [21]. Second to the public
health role of oral health professionals in general, the
significance of the dentists' role in supporting their patients'
attempts to discontinue tobacco use was first mentioned by
Arden G. Christen in 1970 [22]. In two systematic reviews,
Needleman and colleagues concluded that it was reasonable
to assume that the dental setting provided a promising
environment for supporting tobacco use cessation attempts
[9, 23]. In order to facilitate the adoption of tobacco use
prevention and cessation (TUPAC) strategies by dental
practitioners, a multilevel model of care was introduced with
the recent 2nd European Workshop on Tobacco Use Preven-
tion and Cessation for Oral Health Professionals [24, 25].
This approach includes three strategies for providing TUPAC
to patients in a dental setting, with basic or brief inter-
ventions of a couple of minutes, intermediate interventions
of 5–10 min and advanced interventions of 20 min or more.
All three levels of care include an assessment of the patients'
cigarette smoking habit using self-reported data. This
approach is widely used, although it has been reported to
underestimate the true prevalence and quantity of cigarette
smoking [10–12].
Smoking behaviour of patients can be estimated by
interview, self-reported questionnaire or by biochemical
analysis. Simple biochemical methods to validate smoking
status have been available for many years and have proven
to be the gold standard [26]. Inaccurate and/or false
reporting of cigarette smoking may occur for many reasons.
Possible explanations may be that many patients have
reported to smoke 20 cigarettes a day because this figure is
the number of cigarettes per pack and may therefore serve
as a convenient response. Additionally, there may be
cultural pressures that influence the self-reporting of
cigarette consumption [27]. More complicated but objective
methods for biochemical analysis of smoking behaviour
have been reported such as measurements of systemic
levels of nicotine, cotinine, thyocyanate, anabasine and
anatabine in plasma, saliva and urine [28]. Concerns with
these techniques, regarding their implementation in a dental
setting for the assessment of smoking behaviour and
monitoring of TUPAC, arise from both their invasiveness
and associated costs. In contrast, CO monitoring is a simple
and inexpensive method. The cut-off value for the
categorization of individuals as either positive or negative
for smoking has been recommended to be 8–10 ppm [29].
CO measurements are reported to be reasonably specific for
detecting heavy cigarette smokers, but especially for light
smokers, environmental sources of CO of similar magni-
tude can pose problems in diagnosis and monitoring of
smoking behaviour [30].
For the two groups analysed, the percentage of current
and former smokers as well as the mean amount of
cigarettes smoked per day was not statistically significantly
different. Differences between the two populations evaluated
were found for the cumulated pack years, where the patients in
group 1 (oral medicine group) exhibited significantly higher
Table 2 Exhaled CO values (in parts per million) for current smokers,
former smokers and non-smokers in both cohorts (n=237)
Non-smokers
(n=87)
Current smokers
(n=88)
Former smokers
(n=62)
Mean 3.06 16.97 3.68
Maximum 10 76 15
Minimum 1 2 1
95% CI 2.66–3.45 14.30–19.64 2.98–4.38
Never smokers Former smokers Current smokers Total
CO values from 0–6 ppm (1) 81 51 19 151
CO values from 7–10 ppm (1) 5 10 9 24
CO values from 11–25 ppm (2) 1 1 43 45
CO values >25 ppm (3) 0 0 17 17
Total 87 62 88 237
Table 3 Correlation between
self-reported smoking status
and corresponding exhaled CO
values (in ppm) in both groups
1, non-/former smokers; 2, light
smokers, 1-10 cigarettes per
day; 3, heavy smokers, more
than 10 cigarettes per day
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values. A possible explanation for this is the difference in the
mean age for subjects included, with patients in the oral
medicine population being almost 15 years older on average.
Nevertheless, the exhaled CO values did not statistically
significantly differ between the two groups. The self-reported
smoking habits exhibited positive correlation with the
exhaled CO values (Table 3), which was further expressed
by the fact that one additional pack year as well as one
additional cigarette smoked per day per patient resulted in
statistically significant higher CO values of 0.16 and
0.88 ppm, respectively.
The finding that 28 out of 88 included current smokers
exhibited low CO values of 2–10 ppm could have been
influenced by the time of measurement for this study
(8.00 a.m. to 12.00 noon). Although both serum nicotine
and CO–haemoglobin levels were found to be increased in
the afternoon in heavy smokers [31], a specific or ideal time
during the day for measuring exhaled CO levels for the
assessment of current smoking behaviour has not been
mentioned in the literature [32, 33]. Thus, it seems
reasonable to assume that light smokers may have not
smoked a cigarette when being examined in the morning,
therefore resulting in lower CO values. Further studies
should address the influence of different measurement time
points during the day on the evaluation of exhaled CO
values, for example late morning versus late afternoon.
Although intermediate and intensive care levels for
TUPAC recommended for the dental setting contain several
interventions including pharmacotherapy [24, 25], a vali-
dation of self-reported smoking status versus objectively
measured tobacco dependence for smoking cessation
interventions in dental practices has not been addressed in
the literature. The application of exhaled CO level measure-
ments for tobacco use cessation in dentistry may be used
for documentation [34] and monitoring of patients. Fur-
thermore, the potential of this device to motivate patients to
quit smoking has to be addressed. Since this study
demonstrates its validity in oral care applications, future
clinical trials in the dental domain should use this tool to
evaluate its benefits and limits in TUPAC.
Conclusions
Based on the results of this study, exhaled CO level
measurements for the assessment of current smoking
behaviour of patients in a dental unit are robust and highly
reproducible. Nevertheless, further studies are needed to
establish the best time of day to measure exhaled CO
values. Even though CO measurements have been taken
between 8.00 a.m. to 12.00 noon, with all patients in this
study, the correlation between self-reported smoking
habits and exhaled CO values proved to be highly valid.
This finding was further confirmed by the fact that the
consumption of an additional pack year for each smoker
resulted in an increase of exhaled CO values by 0.16 ppm
(p=0.003). Moreover, one additional cigarette smoked per
day elevated the CO measurements by 0.88 ppm (p<0.001).
Therefore, the CO monitor could offer a non-invasive
method in a dental setting to objectively assess current
smoking behaviour and to monitor tobacco use cessation
attempts especially when intermediate or intensive care
levels of TUPAC are provided.
Acknowledgements The study was supported by University of Bern
departmental funds and also funds from the National Stop Smoking
Program of Switzerland, which is funded by the Tobacco Control
Fund and the Swiss Cancer League. There are no financial relations
between any author and a commercial company that may pose a
conflict of interest.
References
1. Doll R, Peto R, Boreham J, Sutherland I (2004) Mortality in
relation to smoking: 50 years' observation on male British doctors.
BMJ 328:1097–1102
2. Patel RR, Ryu JH, Vassallo R (2008) Cigarette smoking and
diffuse lung disease. Drugs 68:1511–1527
3. Gupta PC, Murti PR, Bhonsle RB (1996) Epidemiology of cancer
by tobacco products and the significance of TSNA. Crit Rev
Toxicol 26:183–198
4. Gandini S, Botteri E, Iodice S, Boniol M, Lowenfels AB,
Maisonneuve P, Boyle P (2008) Tobacco smoking and cancer: a
meta-analysis. Int J Cancer 122:155–164
5. Johnson NW, Bain CA (2000) Tobacco and oral disease. EU-
Working Group on Tobacco and Oral Health. Br Dent J 189:200–
206
6. Reichart PA (2001) Identification of risk groups for oral precancer
and cancer and preventive measures. Clin Oral Investig 5:207–
213
7. Warnakulasuriya S, Dietrich T, Bornstein MM, Peidró EC,
Preshaw PM, Walter C, Wennström JL, Bergström J (2010) Oral
health risks of tobacco use and effects of cessation. Int Dent J
60:7–30
8. Victoroff KZ, Lewis R, Ellis E, Ntragatakis M (2006) Patient
receptivity to tobacco cessation counseling in an academic dental
clinic: a patient survey. J Public Health Dent 66:209–211
9. Needleman IG, Binnie VI, Ainamo A, Carr AB, Fundak A,
Koerber A, Ohrn K, Rosseel J (2010) Improving the effectiveness
of tobacco use cessation (TUC). Int Dent J 60:50–59
10. Daly RJ, Blann AD (1996) Self-reported smoking in vascular
disease: the need for biochemical confirmation. Br J Biomed Sci
53:204–208
11. Coultas DB, Howard CA, Peake GT, Skipper BJ, Sarnet JM
(1988) Discrepancies between self-reported and validated cigarette
smoking in a community survey of New Mexico Hispanics. Am
Rev Respir Dis 137:810–814
12. Gorber SC, Schofield-Hurwitz S, Hardt J, Levasseur G, Tremblay M
(2009) The accuracy of self-reported smoking: a systematic review of
the relationship between self-reported and cotinine-assessed smoking
status. Nicotine Tob Res 11:12–24
13. Scherer G, Richter E (1997) Biomonitoring exposure to environ-
mental tobacco smoke (ETS): a critical reappraisal. Hum Exp
Toxicol 16:449–459
Clin Oral Invest (2012) 16:755–760 759
14. Ramseier CA, Mattheos N, Needleman I, Watt R, Wickholm S
(2006) Consensus report: First European Workshop on Tobacco
Use Prevention and Cessation for Oral Health Professionals. Oral
Health Prev Dent 4:7–18
15. Ramseier CA, Bornstein MM, Saxer UP, Klingler K, Walter C
(2007) Tobacco use prevention and cessation in the dental
practice. Schweiz Monatsschr Zahnmed 117:253–278, in German
16. Andersson MF, Moller AM (2010) Assessment of carbon
monoxide values in smokers: a comparison of carbon monoxide
in expired air and carboxyhaemoglobin in arterial blood. Eur J
Anaesthesiol 27:812–818
17. Middleton ET, Morice AH (2000) Breath carbon monoxide as an
indication of smoking habit. Chest 117:758–763
18. Watt RG, Benzian H, Binnie V, Gafner C, Hovius M, Newton TJ,
Mecklenburg RE (2006) Public health aspects of tobacco control:
setting the agenda for action by oral health profession across
Europe. Oral Health Prev Dent 4:19–26
19. Gallagher JE, Alajbeg I, Büchler S, Carrassi A, Hovius M, Jacobs A,
Jenner M, Kinnunen T, Ulbricht S, Zoitopoulos L (2010) Public
health aspects of tobacco control revisited. Int Dent J 60:31–49
20. Bornstein MM, Frei M, Sendi P, Ramseier CA, Reichart PA (2010)
Patients' awareness of the potential benefit of smoking cessation.
A study evaluating self-reported and clinical data from patients
referred to an oral medicine unit. Clin Oral Invest. doi:10.1007/
s00784-010-0488-5
21. Black JH 3rd (2010) Evidence base and strategies for successful
smoking cessation. J Vasc Surg 51:1529–1537
22. Christen AG (1970) The dentist's role in helping patients to stop
smoking. J Am Dent Assoc 81:1146–1152
23. Needleman I, Warnakulasuriya S, Sutherland G, Bornstein MM,
Casals E, Dietrich T, Suvan J (2006) Evaluation of tobacco use
cessation (TUC) counselling in the dental office. Oral Health Prev
Dent 4:27–47
24. Davis JM, Ramseier CA, Mattheos N, Schoonheim-Klein M,
Compton S, Al-Hazmi N, Polychronopoulou A, Suvan J, Antohé
ME, Forna D, Radley N (2010) Education of tobacco use
prevention and cessation for dental professionals—a paradigm
shift. Int Dent J 60:60–72
25. Ramseier CA, Warnakulasuriya S, Needleman IG, Gallagher JE,
Lahtinen A, Ainamo A, Alajbeg I, Albert D, Al-Hazmi N, Antohe
E, Beck-Mannagetta J, Benzian H, Bergstrom J, Binnie V,
Bornstein M, Buchler S, Carr A, Carrassi A, Peidro EC, Compton
S, Crail J, Crews K, Davis JM, Dietrich T, Enmark B, Fine J,
Gallagher J, Jenner T, Forna D, Fundak A, Gyenes M, Hovius M,
Jacobs A, Kinnunen T, Knevel R, Koerer A, Labella R, Lulic M,
Mattheos N, McEwen A, Needleman I, Ohrn K, Polychronopoulou
A, Preshaw P, Radley N, Ramseier C, Rosseel J, Schoonheim-Klein
M, Suvan J, Ulbricht S, Verstappen P, Walter C, Wennstrom J,
Wickholm S, Zoitopoulos L (2010) Consensus report: 2nd European
workshop on tobacco use prevention and cessation for oral health
professionals. Int Dent J 60:3–6
26. Scott DA, Palmer RM, Stapleton JA (2001) Validation of smoking
status in clinical research into inflammatory periodontal disease. J
Clin Periodontol 28:715–722
27. Wells AJ, English PB, Posner SF, Wagenknecht LE, Perez-Stable
EJ (1998) Misclassification rates for current smokers misclassified
as nonsmokers. Am J Public Health 88:1503–1509
28. SNRT Subcommittee on Biochemical Verification (2002) Biochem-
ical verification of tobacco use and cessation. Nicotine Tob Res 2002
(4):149–159
29. Raiff BR, Faix C, Turturici M, Dallery J (2010) Breath carbon
monoxide output is affected by speed of emptying the lungs:
implications for laboratory and smoking cessation research.
Nicotine Tob Res 12:834–838
30. Taniguchi S, Niitsuya M, Inoue Y, Katagiri H, Kadowaki T,
Aizawa Y (1999) Evaluation of passive smoking by measuring
urinary trans, trans-muconic acid and exhaled carbon monoxide
levels. Ind Health 37:88–94
31. Zevin S, Gourlay SG, Benowitz NL (1998) Clinical pharmacology
of nicotine. Clin Dermatol 16:557–564
32. Simmons MS, Connett JE, Nides MA, Lindgren PG, Kleerup EC,
Murray RP, Bjornson WM, Tashkin DP (2005) Smoking reduction
and the rate of decline in FEV(1): results from the Lung Health
Study. Eur Respir J 25:1011–1017
33. Hughes J, Lindgren P, Connett J, Nides M (2004) Smoking
reduction in the Lung Health Study. Nicotine Tob Res 6:275–
280
34. Nasry HA, Preshaw PM, Stacey F, Heasman L, Swan M, Heasman
PA (2006) Smoking cessation advice for patients with chronic
periodontitis. Br Dent J 200:272–275
760 Clin Oral Invest (2012) 16:755–760
